FBTTX Mutual Fund (Fidelity Advisor Biotechnology Fund Class M) is managed by Fidelity Investments (US) with $136.3M in net assets. FBTTX expense ratio is 1.21%, holding 92 positions across sectors including Health Care, Financials, Unknown. Inception date: 2000-12-27.

FBTTX performance shows a YTD return of 22.26%. The 1-year return is 76.68% and the 5-year return is 12.09%. FBTTX dividend yield stands at 1.03%, paid semi-annually.

FBTTX top holdings include Abbvie Inc (16.6%), Gilead Sciences Inc (6.6%), Alnylam Pharmace (5.0%), Ascendis Pharma As Adr (4.5%), Cogent Biosciences Inc (3.8%). View all FBTTX holdings, sector breakdown, or dividend history.

FBTTX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBTTX alternatives are available via the screener, along with tax-loss harvesting opportunities.